Saturday, February 14, 2026
ADVT 
International

UK PM Johnson to visit India on April 21 to strengthen ties

Darpan News Desk, 20 Apr, 2022 10:45 AM
  • UK PM Johnson to visit India on April 21 to strengthen ties

UK Prime Minister Boris Johnson will pay an official visit to India from April 21-22. This will be his maiden visit to India as Prime Minister, said the Ministry of External Affairs on Sunday.

During the two-day meet, the British Prime Minister will first land in Ahmedabad on April 21 and then proceed to Delhi.

The ministry statement said, "At the invitation of Prime Minister Shri Narendra Modi, the Rt. Hon'ble Boris Johnson MP, Prime Minister of the United Kingdom will pay an official visit to India from 21-22 April 2022. This will be his maiden visit to India as Prime Minister of the United Kingdom."

During the visit, Prime Minister Narendra Modi and the UK PM are likely to discuss trade, defence and the Ukraine crisis.

"The Prime Ministers will review implementation of the Roadmap 2030 and set their vision for further intensifying cooperation across the full spectrum of bilateral ties. They will also exchange views on regional and global issues of mutual interest," said the ministry.

"Prime Minister Johnson will be accorded a ceremonial welcome at Rashtrapati Bhavan and will hold bilateral consultations with the Prime Minister on April 22. Besides official engagements in New Delhi, the Prime Minister of the United Kingdom will also visit Gujarat on April 21.

"India and the United Kingdom enjoy a long and historical relationship which was elevated to a Comprehensive Strategic Partnership during the India-UK Virtual Summit in 2021," said the ministry in a statement.

MORE International ARTICLES

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports